MedPath

Enhanced Safety Laser Hair Removal System

Not Applicable
Conditions
Hirsutism
Hypertrichosis
Registration Number
NCT00441948
Lead Sponsor
Scilex Ltd.
Brief Summary

The purpose of this study is to determine whether a new laser system provides better safety and efficacy in hair removal than existing lasers.

Detailed Description

Lasers are a well-established, popular modality for removal of unwanted hair. The existing lasers are based on a wavelength that is specifically absorbed by the pigment melanin found in the hair follicle, where the energy is converted to heat resulting in a thermal injury.

However, lasers for hair removal are not without limitations. A laser based long-term hair removal treatment is based on thermal destruction of the hair shaft and follicle using wavelengths that are specifically absorbed by the pigment melanin found in the hair follicle. The heating of hair follicle is done through heat dissipation from the hair shaft. One of the significant limitations of this approach is the fact that the epidermis through which the light energy must penetrate is rich in melanin and therefore absorbs a major portion of the energy, resulting in inadequate heating of the hair follicles. The purpose of the study is an evaluation safety and efficacy of a new laser based device.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Age between 18 and 75 years old
  • Fitzpatrick skin types I to VI
Read More
Exclusion Criteria
  • Age below 18 or above 75 year old
  • Use of photosensitive medications
  • Photosensitive diseases
  • Active infection of any type and active infection or or a history of Herpes Simplex in the treated site
  • Exposure to sun or artificial tanning during the last 3-4 weeks
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Hair reduction as counted 1-3 months after each treatment session, depending on the treated area.
Long term clearance will be calculated as the ratio between the value of the baseline hair count taken immediately before the first treatment, and the value obtained at the 3-6 month post treatment hair count.
Secondary Outcome Measures
NameTimeMethod
Measuring treatment discomfort as graded by the patients.

Trial Locations

Locations (1)

Hadassah Medical Center, Dermatology

🇮🇱

Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath